- Home
- DSX vs INBX Comparison
DSX vs INBX Comparison
Compare DSX & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSX
- INBX
- Stock Information
- Founded
- DSX 1999
- INBX 2010
- Country
- DSX Greece
- INBX United States
- Employees
- DSX N/A
- INBX N/A
- Industry
- DSX Marine Transportation
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- DSX Consumer Discretionary
- INBX Health Care
- Exchange
- DSX Nasdaq
- INBX Nasdaq
- Market Cap
- DSX 172.5M
- INBX 178.5M
- IPO Year
- DSX 2005
- INBX 2020
- Fundamental
- Price
- DSX $1.60
- INBX $22.86
- Analyst Decision
- DSX
- INBX Hold
- Analyst Count
- DSX 0
- INBX 1
- Target Price
- DSX N/A
- INBX N/A
- AVG Volume (30 Days)
- DSX 276.8K
- INBX 127.6K
- Earning Date
- DSX 07-30-2025
- INBX 08-12-2025
- Dividend Yield
- DSX 2.44%
- INBX N/A
- EPS Growth
- DSX N/A
- INBX N/A
- EPS
- DSX 0.05
- INBX 111.58
- Revenue
- DSX $225,498,000.00
- INBX $200,000.00
- Revenue This Year
- DSX N/A
- INBX N/A
- Revenue Next Year
- DSX $12.09
- INBX N/A
- P/E Ratio
- DSX $31.07
- INBX $0.21
- Revenue Growth
- DSX N/A
- INBX N/A
- 52 Week Low
- DSX $1.27
- INBX $10.80
- 52 Week High
- DSX $2.86
- INBX $24.30
- Technical
- Relative Strength Index (RSI)
- DSX 57.02
- INBX 85.32
- Support Level
- DSX $1.48
- INBX $20.48
- Resistance Level
- DSX $1.68
- INBX $15.25
- Average True Range (ATR)
- DSX 0.05
- INBX 1.33
- MACD
- DSX 0.01
- INBX 0.72
- Stochastic Oscillator
- DSX 72.73
- INBX 85.52
About DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.